Judges appt not part of judiciary's independence: Gowda

June 11, 2015

New Delhi, Jun 11: Appointment of judges is not an integral part of independence of judiciary, asserts Law Minister D V Sadananda Gowda, who also dismisses fears that the National Judicial Appointments Commission is tilted in favour of the executive.sadananda gowda

He also asserts that the primacy of the judiciary will always be there in the appointments, notwithstanding the fact that the collegium will not exist.

"The appointment of judges is not an integral part of independence of the judiciary. The appointment of judges is an executive function because the orders will be issued by an executive order.

"It passes through the various stages and goes to the Prime Minister. Finally the President will act. So, it will not be a judicial order, it will be an executive function," he told in an interview.

Gowda's remarks come in the midst of a hearing in the Supreme Court on the validity of the NJAC Act in which the Centre has attacked the collegium system of judges appointing judges saying that it did not follow the principle of meritocracy in which many "undeserving" persons became judges.

Gowda also responded to a question on fears that the end of the over two decade-long collegium system would mean an end of the judiciary's supremacy in appointing judges.

"Taking (away) the primacy of judiciary...that does not arise. Apart from that, I want to make it very clear that the constitution of the NJAC is made in such a way that the responsibility of the Executive is very little. Only one member of the government (the Law Minister) is there.

"The primacy of the judiciary is kept, because it is presided over by the Chief Justice of India and two senior judges of the Supreme Court are the members. Two eminent persons will be selected by the PM, the Leader of the Opposition (in the Lok Sabha) and the CJI," Gowda said.

Under the collegium system, the CJI, along with four other senior judges of the Supreme Court, used to recommend names of judges for the apex court and 24 High Courts.

Government was free to return their recommendation only once for reconsideration.

Responding to suggestions that the two eminent persons on the Commission could 'tilt' the decisions in favour of the government, the Law Minister said the PM, CJI and Leader of the Opposition who nominate the two eminent persons to the Commission "are from three (different) corners".

"In democracy, at no point of time, the Opposition and ruling party have gone together, nowhere in the history. Judiciary can't say that the opposition leader and PM will join hands. It is highly impossible on this earth.

"So, selection of two eminent personalities is also done in such a way, it is very transparent and it cannot be biased or it cannot be single-sided action. The CJI presides over the commission and veto powers are there. So nobody can say that," he said.

Responding to the people who come in the criteria of being 'eminent persons', he said at the meeting of the selection committee, everybody can suggest the norms on who can be the eminent person.

"The criteria and other things, credentials can also be discussed in the committee. It is quite transparent just like debate in Parliament," he said.

He also expressed concern at the over 350 vacancies in 24 high courts. The rise in vacancies is also due to the fact that government had recently enhanced the strength in HCs by 25 per cent.

"But we thought that NJAC, as soon as it is formed, vacancies will be cleared immediately. But as the NJAC Act is under judicial scrutiny, a little delay is there. I do concede. But we requested the Supreme Court for extension of period of some additional judges. They have extended their tenure for three months.

"The vacancies have to be filled up. These include the enhanced strength of 25 per cent. The vacancies will continue till the case is settled. Certainly. Unless the Supreme court gives its judgement, we are not in a position to go ahead," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 9,2020

New Delhi, May 9: Home Minister Amit Shah today tweeted to say he is healthy and not suffering from any disease, dismissing recent rumours on social media about his health. "I want to make it clear that I am completely healthy and do not suffer from any disease," the Home Minister wrote.

The 55-year-old home minister said for the last few days, some people on social media have been spreading rumours about his health. "In fact, many have tweeted even wishing for my death," he said.

मेरे स्वास्थ्य की चिंता करने वाले सभी लोगों को मेरा संदेश। pic.twitter.com/F72Xtoqmg9

— Amit Shah (@AmitShah) May 9, 2020
Mr Shah said with the country fighting the coronavirus pandemic, that has affected nearly 40,000 people and killed more than 1,900, he did not pay attention to these rumours as he was busy performing his duties as the home minister. He said he was clarifying today because lakhs of BJP workers have expressed concern over the last two days.

The Home Minister, taking a jibe at those spreading rumours, said such speculation about his health will only make him stronger. "I request people to stop indulging in such talks and let me do my work, they should also go about their business," he added.

Amit Shah thanked well-wishers and workers of the BJP for enquiring about his health. He signed off by saying he has no hatred towards those who spread the rumours.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 27,2020

New Delhi, Apr 27: The number of COVID-19 cases climbed to 28,380 and the death toll due to it rose to 886 in the country on Monday, registering a record increase of 60 deaths in 24 hours, according to the Union Health Ministry.

There has been a spike of 1,463 cases since Sunday evening.

The number of active COVID-19 cases stood at 21,132, while 6,361 people have recovered, and one patient has migrated, the ministry said.

Thus, around 22.41 per cent of patients have recovered in the country so far.

The total number of cases includes 111 foreign nationals.

A total of 60 deaths were reported since Sunday evening, of which 19 fatalities were reported from Maharashtra, 18 from Gujarat, eight from Rajasthan, seven from Madhya Pradesh, two each from Karnataka, West Bengal and Uttar Pradesh, and one each from Punjab and Tamil Nadu.

Of the 886 deaths, Maharashtra tops the tally with 342 fatalities, followed by Gujarat at 151, Madhya Pradesh at 106, Delhi at 54, Rajasthan at 41, and Andhra Pradesh and Uttar Pradesh at 31 each.

The death toll reached 26 in Telangana, 24 in Tamil Nadu while West Bengal and Karnataka have reported 20 deaths each.

Punjab has registered 18 fatalities so far. The disease has claimed six lives in Jammu and Kashmir, four in Kerala while Jharkhand and Haryana have recorded three COVID-19 deaths each.

Bihar has reported two deaths, while Meghalaya, Himachal Pradesh, Odisha and Assam have reported one fatality each, according to the ministry data.

According to the Health Ministry data updated in the evening, the highest number of confirmed cases in the country are from Maharashtra at 8,068, followed by Gujarat at 3,301, Delhi at 2,918, Rajasthan at 2,185, Madhya Pradesh at 2,168, Uttar Pradesh at 1,955 and Tamil Nadu at 1,885.

The number of COVID-19 cases has gone up to 1,177 in Andhra Pradesh and 1,002 in Telangana.

The number of cases has risen to 649 in West Bengal, 523 in Jammu and Kashmir, 511 in Karnataka, 469 in Kerala, 313 in Punjab and 289 in Haryana.

Bihar has reported 277 novel coronavirus cases, while Odisha has 108 cases. Eighty-two people have been infected with the virus in Jharkhand and 51 in Uttarakhand.

Himachal Pradesh has 40 cases, Chhattisgarh has 37 and Assam has registered 36 infections each so far.

Andaman and Nicobar Islands has 33 COVID-19 cases while Chandigarh has 30 cases and Ladakh has reported 20 infections so far.

Meghalaya has reported 12 cases, Puducherry has eight cases while Goa has seven COVID-19 cases.

Manipur and Tripura have two cases each, while Mizoram and Arunachal Pradesh have reported a case each.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.